Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
Abeona Therapeutics (ABEO) Ownership - Who Owns Abeona Therapeutics?
1,251 Followers
Abeona Therapeutics (ABEO) Ownership Overview
51.34% Insiders
4.87% Mutual Funds
4.26% Other Institutional Investors
39.53% Public Companies and Individual Investors
The ownership structure of Abeona Therapeutics (ABEO) stock is a mix of institutional, retail and individual investors. Approximately 9.13% of the company’s stock is owned by Institutional Investors, 51.34% is owned by Insiders and 39.53% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 26, 2024 | Bought | $17609 | |
| Apr 26, 2024 | Brendan M. O'malley Svp & Gc | Bought | $27864 |
| Feb 07, 2024 | Vishwas Seshadri Ceo,director | Bought | $87800 |
| Jan 22, 2024 | Mark Alvino Director | Sold | $36199 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $4048641 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,058,903 | Institution | 3.87% | 3,610,859 | |
| 1,044,133 | Institution | 3.82% | 3,560,494 | |
| 869,565 | Institution | 3.18% | 2,965,217 | |
| 808,112 | Institution | 2.95% | 2,755,662 | |
| 215,462 | Institution | 0.79% | 734,725 | |
| 86,724 | Institution | 0.32% | 295,729 | |
| 23,529 | Institution | 0.09% | 80,234 | |
| 23,500 | Institution | 0.09% | 80,135 | |
| 8,850 | Institution | 0.03% | 30,179 | |
| 6,696 | Institution | 0.02% | 22,833 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,044,133 | Institution | 3.82% | 3,560,494 | |
| 215,462 | Institution | 0.79% | 734,725 | |
| 23,529 | Institution | 0.09% | 80,234 | |
| 23,500 | Institution | 0.09% | 80,135 | |
| 8,850 | Institution | 0.03% | 30,179 | |
| 6,696 | Institution | 0.02% | 22,833 | |
| 5,777 | Institution | 0.02% | 19,700 | |
| 4,987 | Institution | 0.02% | 17,006 | |
| 280 | Institution | <0.01% | 955 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 739,765 | Institution | 2.70% | 5,363,296 | |
| 319,138 | Institution | 1.17% | 2,313,751 | |
| 46,354 | Institution | 0.17% | 158,067 | |
| 38,685 | Institution | 0.14% | 131,916 | |
| 3,872 | Institution | 0.01% | 13,204 | |
| 1,685 | Institution | <0.01% | 12,402 | |
| 60 | Institution | <0.01% | 205 |
FAQ
Who Owns Abeona Therapeutics (ABEO)?
According to the latest TipRanks data, approximately 4.26% of the company's stock is held by institutional investors, 51.34% is held by insiders, and 39.53% is held by retail investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.26% of Abeona Therapeutics (ABEO) stock is held by institutional investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.53% of Abeona Therapeutics (ABEO) stock is held by retail investors.
Who owns the most shares of Abeona Therapeutics (ABEO)?
Vanguard owns the most shares of Abeona Therapeutics (ABEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.